A proposed mechanism for chlorpromazine jaundice — defective hepatic sulphoxidation combined with rapid hydroxylation
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 7 (1) , 72-78
- https://doi.org/10.1016/s0168-8278(88)80508-7
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- High Incidence of Poor Sulfoxidation in Patients with Primary Biliary CirrhosisNew England Journal of Medicine, 1988
- Genetic aspects of the polymodally distributed sulphoxidation of S‐ carboxymethyl‐L‐cysteine in man.British Journal of Clinical Pharmacology, 1984
- Polymorphic sulphoxidation of S-carboxymethyl-L-cysteine in manBiochemical Pharmacology, 1982
- A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.Journal of Medical Genetics, 1980
- Variation in human metabolism of S-carboxymethylcysteineEuropean Journal of Drug Metabolism and Pharmacokinetics, 1980
- Chlorpromazine and Its Metabolites Alter Polymerization and Gelation of ActinScience, 1979
- The metabolism of [14C]‐debrisoquine in man.British Journal of Clinical Pharmacology, 1979
- Effects of chlorpromazine hydrochloride on bile salt synthesis, bile formation and biliary lipid secretion in the Rhesus monkey: a model for chlorpromazine‐induced cholestasisEuropean Journal of Clinical Investigation, 1979
- The Metabolism ofS-Carboxymethylcysteine in Rodents, Marmosets and HumansXenobiotica, 1978
- Biliary Cirrhosis Induced by ChlorpromazineGastroenterology, 1966